Cargando…
Current Therapeutic Options for Heart Failure in Elderly Patients
Heart failure (HF) is a major and growing public health problem with high morbidity and mortality (Ponikowski et al., 2016). It affects 1-2% of the general population in developed countries, and the average age at diagnosis is 76 years. Because of a better management of acute phase and comorbidities...
Autores principales: | Guerra, F., Brambatti, M., Matassini, M. V., Capucci, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705868/ https://www.ncbi.nlm.nih.gov/pubmed/29270425 http://dx.doi.org/10.1155/2017/1483873 |
Ejemplares similares
-
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders
por: Martínez-Bailén, Macarena, et al.
Publicado: (2022) -
Peritoneal dialysis as therapeutic option in heart failure patients
por: Grossekettler, Leonie, et al.
Publicado: (2019) -
Exercise: a “new drug” for elderly patients with chronic heart failure
por: Antonicelli, Roberto, et al.
Publicado: (2016) -
Vasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?
por: De Vecchis, Renato, et al.
Publicado: (2016) -
Reviewing the Modern Therapeutical Options and the Outcomes of Sacubitril/Valsartan in Heart Failure
por: Iovanovici, Diana-Carina, et al.
Publicado: (2022)